Health Workforce Economics

Core Idea

Health workforce economics examines how labor markets for physicians, nurses, and other health professionals function — and why they persistently deviate from competitive market predictions. The supply of physicians is artificially constrained by lengthy training requirements (4 years medical school plus 3-7 years residency), limited medical school and residency slots (partly funded by Medicare GME payments in the US), and licensing barriers. Demand for health workers is derived demand — it depends on the population's demand for healthcare, which is itself shaped by insurance coverage, demographics, disease burden, and technology. Key policy questions include whether physician shortages are real or reflect maldistribution (too many specialists, too few primary care doctors; too many in cities, too few in rural areas), how scope-of-practice regulations for nurse practitioners and physician assistants affect access and cost, and whether training subsidies produce an adequate return on public investment.

Explainer

The health workforce is the single largest cost component of healthcare systems worldwide, typically accounting for 60-80% of total health expenditure. Understanding the economics of health labor markets is therefore essential for understanding healthcare costs, access, and quality. But health labor markets are among the most regulated and unusual labor markets in any economy, and standard competitive market models fail to capture their most important features.

The supply side is defined by extreme barriers to entry. Becoming a physician requires a bachelor's degree (4 years), medical school (4 years), and residency training (3-7 years depending on specialty), plus licensing examinations at multiple stages. This 11-15 year training pipeline means that supply cannot respond quickly to demand changes — a decision to expand medical school capacity today will not produce additional practicing physicians for a decade. The number of residency slots, which is the binding constraint on physician supply in the US, is substantially determined by government policy (Medicare GME funding) rather than market forces. Nursing, pharmacy, and allied health professions face their own pipeline constraints, including clinical training site availability and faculty shortages in nursing programs.

The demand side is driven by population health needs filtered through payment systems. An aging population increases demand for geriatricians, cardiologists, and orthopedists. Expansion of insurance coverage (as under the ACA) increases demand by converting unmet need into funded demand. New technologies create demand for specialists trained to use them. But demand is also shaped by physician-induced demand — the ability of providers, who have more information than patients, to influence the quantity of services consumed. The evidence on physician-induced demand suggests that it exists but is modest in magnitude; a more powerful effect is that the specialty distribution of physicians shapes utilization patterns, with areas having more specialists consuming more specialist services without clearly better outcomes.

The maldistribution problem — too many specialists relative to primary care, too many urban providers relative to rural — is arguably more important than the absolute supply question. The US trains enough physicians in aggregate but distributes them suboptimally. Specialist-to-primary-care income ratios of 2:1 to 3:1 powerfully steer career choices. Medical students carrying $200,000+ in debt rationally choose specialties that maximize income. Geographic preferences and spouse's career considerations concentrate physicians in desirable metropolitan areas. Policy tools to address maldistribution include loan repayment for underserved-area practice (National Health Service Corps), rural residency training tracks (physicians who train in rural areas are more likely to practice there), expansion of scope-of-practice for nurse practitioners and physician assistants (who are more willing to practice in underserved settings), and telehealth (which decouples specialist access from geographic proximity).

The scope-of-practice debate illustrates the tension between quality regulation and market access. Physicians argue that their longer training produces superior clinical judgment and that independent NP practice risks patient safety. Economists counter that the evidence shows comparable outcomes for primary care, that scope-of-practice restrictions function primarily as anticompetitive barriers that protect physician income at the expense of patient access, and that the appropriate policy is to regulate by demonstrated competence rather than by degree type. The 25 US states that have granted NPs full independent practice authority have not experienced measurable quality declines, while gaining improved access in underserved areas — evidence that has shifted the policy debate substantially toward expanded NP autonomy.